News & Events

All
Blog
COVID-19
Events
News

Moving toward T cell therapy for COVID-19 with single cell immune sequencing

T cell therapy for COVID-19 with single cell immune sequencing

Jul 26, 2021

iRepertoire and BioNTech Webinar featuring Asaf Poran and Kristen Balogh - Predicting patient reponse to neoantigen vaccine+ anti PD-1 therapy in melanoma with TCR repertoire and PBMC phenotypes

BioNTech Webinar | Predicting patient response to neoantigen vaccine + anti PD-1 therapy in melanoma with TCR repertoire and PBMC phenotypes | iRepertoire

Jul 9, 2021

The evolution of antibody-based treatments for infectious disease: From convalescent plasma to single cell immune sequencing. Read case study.

The evolution of antibody-based treatments for infectious disease: From convalescent plasma to single cell immune sequencing

Apr 15, 2021

Immune repertoire sequencing for pre- and post-treatment monitoring in cancer. Read case study.

Immune Repertoire Sequencing for Pre- and Post-Treatment Monitoring in Cancer

Apr 14, 2021

New discovery in malaria - Blazing a trail for developing antibody-based treatments for COVID-19. Read now.

New discovery in malaria blazes a trail for developing antibody-based treatments for COVID-19

Mar 19, 2021

Webinar | When infections get personal: Identifying patient-specific infection responses with multidimensional RNAseq

Webinar | When infections get personal: Identifying patient-specific infection responses with multidimensional RNAseq

Feb 1, 2021

Predicting and measuring patient response to cell therapy with single cell TCR sequencing. Read case study.

Predicting and measuring patient response to cell therapy with single cell TCR sequencing

Jan 20, 2021

Using TCR diversity to model progression-free cancer survival. Surprising parallels with chronic viral infection. Ready study.

New study models TCR repertoire as a biomarker for immunotherapy response—reveals surprising signatures of PFS

Dec 14, 2020

Finding new immunotherapy targets in cancer research. Read study.

Finding new therapeutic targets in cancer research through changes in the immune adaptome

Nov 2, 2020

iPair single cell sequencing demonstrates efficacy of in vitro/in vivo t-cell therapy

Cue Biopharma uses iPair technology to demonstrate efficacy of Tumor Antigen-Specific T Cell activating drug

Oct 29, 2020

A radar map of the immune system's response to COVID-19, published by scientists who discovered SARS

Scientists who discovered SARS just revealed a radar map of the immune system’s response to COVID-19

Oct 19, 2020

Translational Dx Virtual Summit Presentation: Predicting Treatment efficacy from FFPE-damaged tumor samples with immune repertoire profiling. Quantifiying response to cancer treatment via 7-chain immune repertoire sequencing

Translational Dx: Advances in Multi-Omic Oncology

Sep 9, 2020

Dr. Jian Han stands facing the camera in a polished white shirt, slightly smiled. Slightly blurred for the background is the view of an empty lab room at Hudson Alpha Institute for Biotechnology

Presentation from our Founder, Dr. Jian Han

Aug 31, 2020

SARS-CoV-2 virus medical illustration. 3D rendering of a close-up virus has a reddish pink base and blue and teal spike proteins. In the background, 3 more stylized viruses are blurred and smaller, in the distance.

Precision medicine workflow featuring RepSeq+ could help predict organ failure in COVID-19 patients

Jun 29, 2020

Ready to get started?

Let's chat about your project